First Republic Investment Management, Inc. Insmed Inc Transaction History

First Republic Investment Management, Inc.

$34.7 Billion
Q3 2023

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 28, 2023	SELL	$16.44 - $21.1 $23,196 - $29,772	-1,411 Reduced 11.77%	10,581 $223,000
Q1 2023 May 11, 2023	BUY	$16.26 - $21.73 $194,989 - $260,586	11,992 New	11,992 $204,000
Q1 2022 May 16, 2022	SELL	$20.42 - $28.13 $175,264 - $241,439	-8,583 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$25.89 - $33.45 $21,540 - $27,830	832 Added 10.73%	8,583 $234,000
Q3 2021 Nov 12, 2021	BUY	$22.46 - $29.47 $3,189 - $4,184	142 Added 1.87%	7,751 $213,000
Q2 2021 Aug 16, 2021	BUY	$24.17 - $36.01 $15,734 - $23,442	651 Added 9.36%	7,609 $217,000
Q1 2021 May 14, 2021	SELL	$32.28 - $44.3 $9,813 - $13,467	-304 Reduced 4.19%	6,958 $237,000
Q4 2020 Feb 16, 2021	SELL	$31.45 - $40.54 $29,500 - $38,026	-938 Reduced 11.44%	7,262 $242,000
Q3 2020 Nov 12, 2020	SELL	$26.0 - $34.5 $27,482 - $36,466	-1,057 Reduced 11.42%	8,200 $264,000
Q2 2020 Aug 13, 2020	BUY	$14.11 - $29.42 $130,616 - $272,340	9,257 New	9,257 $255,000

Others Institutions Holding INSM

# of Institutions

467

Shares Held

182M

Call Options Held

2.27M

Put Options Held

3.33M

Vanguard Group Inc Valley Forge, PA

17.1M
Shares

$1.2 Billion
0.02% of portfolio
Black Rock Inc. New York, NY

14.3M
Shares

$999 Million
0.02% of portfolio
Price T Rowe Associates Inc Baltimore, MD

12.6M
Shares

$881 Million
0.11% of portfolio
Darwin Global Management, Ltd. St. Helier, Y9

10.5M
Shares

$735 Million
62.32% of portfolio
Capital International Investors Los Angeles, CA

6.52M
Shares

$457 Million
0.09% of portfolio

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $9.48B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.

Account